SI-Bone (NASDAQ: SIBN) net income
SI-Bone reported a net loss of $18.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $30.9m. Earnings per share were −$0.44.
SI-Bone's best year of the last 9 was fiscal 2018. It reported a loss in 9 of those 9 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$18.9m | — | −9.4% | −$0.44 |
| 2024 | −$30.9m | — | −18.5% | −$0.75 |
| 2023 | −$43.3m | — | −31.2% | −$1.13 |
| 2022 | −$61.3m | — | −57.6% | −$1.79 |
| 2021 | −$56.6m | — | −62.8% | −$1.71 |
| 2020 | −$43.7m | — | −59.5% | −$1.50 |
| 2019 | −$38.4m | — | −57.1% | — |
| 2018 | −$17.5m | — | −31.5% | — |
| 2017 | −$23.0m | — | −48.0% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
SI-Bone net income compared with its sector
By net income for its latest fiscal year, SI-Bone ranks 206th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of SI-Bone, −9.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 204th | Ovid Therapeutics | −$17.4m | −240.1% |
| 205th | RadNet | −$18.7m | −0.9% |
| 206th | SI-Bone | −$18.9m | −9.4% |
| 207th | Greenwich Lifesciences | −$19.4m | — |
| 208th | Heron Therapeutics | −$20.2m | −13.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of SI-Bone
- How much did SI-Bone earn in fiscal 2025?
- SI-Bone reported a net loss of $18.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $30.9m.
- What are the earnings per share of SI-Bone?
- They were −$0.44 in fiscal 2025, compared with −$0.75 in fiscal 2024.
- Where does SI-Bone rank in its sector by net income?
- It ranks 206th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for SI-Bone come from?
- From the annual report (Form 10-K) that SI-Bone files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that SI-Bone files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on SI-Bone: the SI-Bone page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.